18 Nov 2022 - Overnight oil stocks continued to show a clear disconnect from the commodity they track. The energy sector is reporting the greatest increase in net profit margins compared to its 5-year average. Whereas oil and gas prices have declined from recent highs, capital management initiatives like increased dividends and share buy backs has led the sector to outperform the broader market.
17 Nov 2022 - A snapshot of the stocks on the move featuring Antilles Gold (ASX:AAU), Mt Monger Resources (ASX:MTM) and Sayona Mining (ASX:SYA).
17 Nov 2022 - Markets fell on Wednesday as investors weighed a gloomy holiday quarter update from Target that pressured retail stocks. Target blamed higher inflation and shifts in consumer spending for the drop in demand for everything from toys to home furnishings. In the background commodity prices are soaring as China lends support to their property market.
17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
16 Nov 2022 - A snapshot of the stocks on the move featuring Bass Oil (ASX:BAS), Stealth Global Holdings (ASX:SGI) and Archer Materials (ASX:AXE).
16 Nov 2022 - Elsewhere, retail stocks also lifted investor sentiment. Walmart shares jumped on a bumper third quarter. The retail giant said that sales were up nearly 9 percent from a year ago, as shoppers flocked to cheaper groceries and other items; shares advanced just over 6.5 per cent. Despite the market rally lithium companies were lower with Lithium America down 3.5 per cent, Albemarle 6.5 per cent lower and Livent falling 6.8 per cent.
15 Nov 2022 - Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Dr Michael Baker provides an update on the company.
15 Nov 2022 - A snapshot of the stocks on the move featuring MSL Solutions (ASX:MSL), Lycaon Resources (ASX: LYN) and Victory Goldfields (ASX:1VG).
15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
15 Nov 2022 - Stocks fell to start the week as investors took a pause from last week’s big rally and digested a slew of corporate and economic news, as digital asset exchanges are rushing to reassure clients that their funds are safe as the collapse of Sam Bankman-Fried’s FTX crypto exchange ricochets through the industry.
